Leyi Wang

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Signaling Pathway

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher Nip, Leyi Wang, Chengfei Liu
CD200/CD200R: Bidirectional Role in Cancer Progression and Immunotherapy. Biomedicines 11 (12) (2023)
Christopher Nip, Leyi Wang, Chengfei Liu
CD200/CD200R: Bidirectional Role in Cancer Progression and Immunotherapy. Biomedicines 11 (12) (2023)
Christopher Nip, Leyi Wang, Chengfei Liu
CD200/CD200R: Bidirectional Role in Cancer Progression and Immunotherapy. Biomedicines 11 (12) (2023)
Christopher Nip, Leyi Wang, Chengfei Liu
CD200/CD200R: Bidirectional Role in Cancer Progression and Immunotherapy. Biomedicines 11 (12) (2023)
Christopher Nip, Leyi Wang, Chengfei Liu
CD200/CD200R: Bidirectional Role in Cancer Progression and Immunotherapy. Biomedicines 11 (12) (2023)